Esophageal and Gastric Varices Clinical Trial
Official title:
A Study on Predicting Esophageal Varices in Liver Cirrhosis Using Tongue Bioinformatics
Verified date | July 2023 |
Source | Qilu Hospital of Shandong University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The goal of this observational study is to compare the tongue bioinformatics of high-risk and low-risk patients with esophageal varices due to liver cirrhosis. The main question of this study is to explore whether there exists a relationship between the degree of esophageal varices and tongue bioinformatics in liver cirrhosis. it aims to answer 2 questions as below: question 1: If these is a significant difference in tongue bioinformatics between patients in liver cirrhosis with high-risk and low-risk of esophageal varices. Question 2; If tongue bioinformatics can be used as a diagnostic basic for testing esophageal varices in liver cirrhosis. Firstly, participants will be divided into two groups according to their degree of esophageal varices from electronic gastroscopy report and CT scan report including high-risk group and low-risk group. Secondly, participants will be asked to show their tongue, including the surface and sublingual veins of tongue, and the tongue images of each participants will be collected by researchers via camera. After finishing tongue image collection, participants will receive a professional tongue diagnosis report in Traditional Chinese Medicine and health suggestion.
Status | Active, not recruiting |
Enrollment | 300 |
Est. completion date | April 2024 |
Est. primary completion date | December 29, 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Patient with liver cirrhosis has been diagnosed according to clinical manifestations, blood test and imaging examination. 2. Patient with abdominal enhanced CT scans and upper gastrointestinal endoscopy, 3. Patient who has signed informed consent forms. Exclusion Criteria: 1. Patient who has previously received endoscopic treatment, transjugular intrahepatic portosystemic shunt (TIPS), splenectomy, Hepatectomy, balloon occlusion of retrograde veins or liver transplantation. 2. Patient with severe ascites or Hepatic encephalopathy is painted. 3. Patient with concurrent primary liver cancer; 4. Patient with concurrent severe infection of other systems; 5. Patient with symptoms of liver cirrhosis subside after antiviral treatment; 6. Patient who is taking beta receptor blockers; 7. Paitent with mental disorders; |
Country | Name | City | State |
---|---|---|---|
China | Qilu Hospital of Shdong University | Jinan | Shandong |
Lead Sponsor | Collaborator |
---|---|
Qilu Hospital of Shandong University | 960th Hospital of PLA, Jinan Central Hospital, Qianfoshan Hospital, Shandong Provincial Hospital |
China,
He C, Liao Q, Fu P, Li J, Zhao X, Zhang Q, Gui Q. Microbiological characteristics of different tongue coatings in adults. BMC Microbiol. 2022 Sep 9;22(1):214. doi: 10.1186/s12866-022-02626-7. — View Citation
Lin Y, Li L, Yu D, Liu Z, Zhang S, Wang Q, Li Y, Cheng B, Qiao J, Gao Y. A novel radiomics-platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients. Hepatol Int. 2021 Aug;15(4):995-1005. doi: 10.1007/s12072- — View Citation
Ou J, Li R, Zeng R, Wu CQ, Chen Y, Chen TW, Zhang XM, Wu L, Jiang Y, Yang JQ, Cao JM, Tang S, Tang MJ, Hu J. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study. Cance — View Citation
Tandon M, Singh H, Singla N, Jain P, Pandey CK. Tongue thickness in health vs cirrhosis of the liver: Prospective observational study. World J Gastrointest Pharmacol Ther. 2020 Aug 8;11(3):59-68. doi: 10.4292/wjgpt.v11.i3.59. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Esophageal varices is diagnosed by electronic gastroscopy | Electronic gastroscopy is a standard method to diagnosis esophageal varices for patients with cirrhosis. Especially, the electronic gastroscopy can detect the degree of esophageal varices detallly, including the diameter and red sign of varices veins. | 6 months | |
Primary | Tongue images analysis by artificial intelligence | Tongue images of participants will be analyzed by using artificial intelligence technology. And the result will be used to test If tongue bioinformatics is related to the degree of esophageal varices in liver cirrhosis. | 6 months | |
Secondary | Specific Characteristic in Tongue Bioinformatics | Artificial intelligence technology and statistic analysis will be used to study the specific difference in tongue bioinformatics between high-risk and low-risk group esophageal varices in patients with liver cirrhosis. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05055713 -
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
|
N/A | |
Recruiting |
NCT02945930 -
Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices
|
N/A | |
Completed |
NCT04823780 -
The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
|
||
Completed |
NCT03244332 -
HEMOCC Study. Hemostasis in Cirrhotic Children.
|
N/A | |
Completed |
NCT02991612 -
Rifaximin in Patients With Gastroesophageal Variceal Bleeding
|
N/A | |
Recruiting |
NCT02964195 -
Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding
|
N/A | |
Completed |
NCT00004641 -
A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis
|
Phase 2 | |
Completed |
NCT02593799 -
Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
|
||
Recruiting |
NCT02719119 -
Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding
|
N/A | |
Recruiting |
NCT02385422 -
The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding
|
Phase 4 | |
Completed |
NCT00838864 -
Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding
|
Phase 4 | |
Not yet recruiting |
NCT03130127 -
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
|
N/A | |
Recruiting |
NCT02504723 -
Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding
|
Phase 4 | |
Withdrawn |
NCT00475592 -
Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy
|
N/A | |
Completed |
NCT05331768 -
Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy
|
N/A | |
Completed |
NCT04210297 -
Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
|
||
Recruiting |
NCT02311608 -
Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
|
N/A | |
Completed |
NCT04976543 -
Safety of Anticoagulant Therapy After Endoscopic Treatment
|
Phase 4 | |
Not yet recruiting |
NCT05978752 -
Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices
|
N/A | |
Recruiting |
NCT02695732 -
The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
|
Phase 4 |